FACTORS ASSOCIATED WITH PROTHROMBOTIC CHANGES IN ADOLESCENTS WITH ESSENTIAL HYPERTENSION
https://doi.org/10.18821/0234-5730-2017-62-3-134-140
Abstract
Cardiovascular diseases (CVDs) are the major cause of worldwide mortality. The most common CVD is essential hypertension (EH), which is registered in 40% of the adult population and 2.4–18% of children and adolescents in Russia. The study of hemostatic status in hypertensive patients indicates to the prothrombotic changes (PTC). Both EH and hemostatic disorders are known to be heredity associated. However factors related to PTC in adolescents with EH are not clearly defined.
The aim of the study was to evaluate factors potentially increasing the frequency of PTC in adolescents with EH.
Material and methods. The heritability, indices of blood pressure monitoring (BPM), hemostasis disorders and thrombophilia gene polymorphisms are studied in 97 Caucasian adolescents (aged of 14–17 years) with EH, living in the Eastern Siberia. 60 adolescents had no PTС (1st clinical group), 37 adolescents had PTС (2nd clinical group). Forty healthy age- and gender-matched adolescents are controls.
Results. We revealed an important contribution of strong family history of thrombosis, stable arterial hypertension, thrombinemia, C/T and T/T allele carriage С677Т MTHFR gene to the development of PTC in adolescents with EH.
Conclusion. Bearing in mind multifactoriality hemostatic changes in pediatric patients with cardiovascular diseases, the further researches in this are necessary.
About the Authors
L. V. RychkovaRussian Federation
Irkutsk, 664003
S. E. Bolshakova
Russian Federation
Irkutsk, 664003
Bolshakova Svetlana E., MD, PhD, researcher of Pediatrics and Neurophysiology Laboratory
M. V. Gomellya
Russian Federation
Irkutsk, 664003
T. A. Bairova
Russian Federation
Irkutsk, 664003
O. N. Berdina
Russian Federation
Irkutsk, 664003
O. V. Bugun
Russian Federation
Irkutsk, 664003
References
1. WHO. Cardiovascular diseases. News bulletin No 317, January 2015. Available at: http://www.who.int/mediacentre/factsheets/fs317/ru. (accessed 02 Febr 2017). (in Russian)
2. Oganov R.G., Timofeeva T.N., Koltunov I.E., Konstantinov V.V., Balanova Yu.A., Kapustina A.V., et al. Epidemiology of arterial hypertension in Russia. The federal monitoring results of 2003–2010. Cardiovascular therapy and prevention. Russian Journal (Kardiovaskulyarnaya terapiya i profilaktika). 2011; 1: 9–13. (in Russian)
3. Aleksandrov A.A., Bubnova M.G., Kislyak O.A., Kon I.A., Leonteva I.V., Rozanov V.B., et al. Prevention of cardiovascular diseases in childhood and adolescence. Russian recommendations. Russian Journal of Cardiology (Rossiyskiy kardiologicheskiy zhurnal). 2012; 6: 1–39. (in Russian)
4. Riley M., Bluhm B. High blood pressure in children and adolescents. Am. Fam. Physician. 2012; 85(7): 693–700.
5. Kolesnikova L.I., Dolgikh V.V., Polyakov V.M., Rychkova L.V. Psychosomatic pathology problems in children. Novosibirsk: Science; 2005. (in Russian)
6. Kozlovskaya I.L., Bulkina O.S., Karpov Yu.A. Treatment-resistant hypertension: a new perspective. Russian Medical Journal. Cardiology (Russkiy meditsinskiy zhurnal. Kardiologiya). 2012; 25: 1238–43. (in Russian)
7. Hamm C.W., Bassand J.P., Agewall S., Bax J., Boersma E., Bueno H., et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 2011; 32(23): 2999–3054.
8. Barkagan Z.S., Momot A.P. Diagnosis and therapy controlled hemostasis disorders. Moscow: Nyudiamed; 2006. (in Russian)
9. Dolgikh V.V., Gomellya M.V., Filippov E.S., Rychkova A.V. Features of coagulation and fibrinolysis in essential hypertension in children. Cardiology. Russian Journal (Kardiologiya). 2015; 55(11): 69–72. (in Russian)
10. Brady T.M., Feld L.G. Pediatric approach to hypertension. Semin. Nephrol. 2009; 29(4): 379–88.
11. Barbato J.E., Zuckerbraun B.S., Overbaus M. Nitric oxide modulates vascular inflammation and intimai hyperplasia in insulin resistance and metabolic syndrome. J. Physiol. Heart. Circ. 2005; 289(1): 228–36.
12. Bairova T.A., Kolesnikova L.I., Dolgikh V.V., Bimbaev A.B., Shadrina N.A. Polymorphism of angiotensin-converting enzyme gene and its role in implementation of essential and symptomatic hypertension. Pediatrics Russian Journal n.a. G.N. Speransky (Pediatriya. Zhurnal im. G.N. Speranskogo). 2009; 88(5): 37–42. (in Russian)
13. Zhdanova L.V., Shcherbakova M.Yu., Reshetnyak G.M., Patrushev L.I., Aleksandrova E.N., Aldarov A.B. The causes of ischemic strokes in children and adolescents. Pediatrics Russian Journal n.a. G.N. Speransky (Pediatriya. Zhurnal im. G.N. Speranskogo). 2011; 90(5): 88–90. (in Russian)
14. Postnov A.Yu., Goncharova L.N., Khasanova Z.B., Birlyukova D.V., Konovalova N.V., Timoshkina E.I., et al. The study of genetic markers of thrombosis in persons with arterial hypertension of the titular population of the Republic of Mordovia. Archive of pathology. Russian journal (Arhiv patologii). 2009; 71(4): 34–6. (in Russian)
15. Scazzone C., Acuto S., Guglielmini E., Campisi G., Bono A. Methionine synthase reductase (MTRR) A66G polymorphism is not related to plasma homocysteine concentration and the risk for vascular disease. Exp. Mol. Pathol. 2009; 86(2): 131–3.
Review
For citations:
Rychkova L.V., Bolshakova S.E., Gomellya M.V., Bairova T.A., Berdina O.N., Bugun O.V. FACTORS ASSOCIATED WITH PROTHROMBOTIC CHANGES IN ADOLESCENTS WITH ESSENTIAL HYPERTENSION. Russian journal of hematology and transfusiology. 2017;62(3):134-140. (In Russ.) https://doi.org/10.18821/0234-5730-2017-62-3-134-140